Adial Historical Financial Ratios

ADIL Stock  USD 1.09  0.01  0.91%   
Adial Pharmaceuticals is presently reporting on over 92 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Dividend Yield of 0.0, PTB Ratio of 0.68 or Days Sales Outstanding of 0.0 will help investors to properly organize and evaluate Adial Pharmaceuticals financial condition quickly.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Adial Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
For more information on how to buy Adial Stock please use our How to buy in Adial Stock guide.

About Adial Financial Ratios Analysis

Adial PharmaceuticalsFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Adial Pharmaceuticals investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Adial financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Adial Pharmaceuticals history.

Adial Pharmaceuticals Financial Ratios Chart

At this time, Adial Pharmaceuticals' EV To Operating Cash Flow is quite stable compared to the past year. Net Debt To EBITDA is expected to rise to 0.42 this year, although the value of Operating Cash Flow Per Share will most likely fall to (5.02).
Add Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Graham NumberShareholders Equity Per Share
Debt To EquityCapex Per Share
Graham Net NetAverage Receivables
Revenue Per ShareInterest Debt Per Share
Debt To AssetsEnterprise Value Over E B I T D A
Short Term Coverage RatiosPrice Earnings Ratio
Price Book Value RatioPrice Earnings To Growth Ratio
Days Of Payables OutstandingDividend Payout Ratio
Price To Operating Cash Flows RatioPrice To Free Cash Flows Ratio
Pretax Profit MarginEbt Per Ebit
Operating Profit MarginEffective Tax Rate
Company Equity MultiplierLong Term Debt To Capitalization
Total Debt To CapitalizationReturn On Capital Employed
Debt Equity RatioEbit Per Revenue
Quick RatioDividend Paid And Capex Coverage Ratio
Net Income Per E B TCash Ratio
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On Equity

Dividend Yield

Dividend Yield is Adial Pharmaceuticals dividend as a percentage of Adial Pharmaceuticals stock price. Adial Pharmaceuticals dividend yield is a measure of Adial Pharmaceuticals stock productivity, which can be interpreted as interest rate earned on an Adial Pharmaceuticals investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.

Book Value Per Share

The ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements.

Capex To Depreciation

The ratio of a company's capital expenditures to its depreciation expenses, indicating how much the company is investing in physical assets relative to the aging of existing assets.

Inventory Turnover

A ratio showing how many times a company's inventory is sold and replaced over a period, indicating the efficiency of inventory management.
Most ratios from Adial Pharmaceuticals' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Adial Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Adial Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
For more information on how to buy Adial Stock please use our How to buy in Adial Stock guide.At this time, Adial Pharmaceuticals' EV To Operating Cash Flow is quite stable compared to the past year. Net Debt To EBITDA is expected to rise to 0.42 this year, although the value of Operating Cash Flow Per Share will most likely fall to (5.02).

Adial Pharmaceuticals fundamentals Correlations

-0.140.240.24-0.07-0.211.00.3-0.510.17-0.13-0.2-0.07-0.45-0.16-0.07-0.21-0.16-0.89-0.06-0.010.13-0.060.25-0.160.28
-0.14-0.02-0.74-0.02-0.05-0.14-0.70.2-0.87-0.070.970.580.49-0.040.580.16-0.230.010.590.570.390.59-0.1-0.520.74
0.24-0.020.120.15-0.980.240.47-0.18-0.11-0.270.08-0.65-0.56-0.78-0.650.0-0.55-0.1-0.65-0.61-0.22-0.641.00.12-0.29
0.24-0.740.12-0.48-0.020.240.9-0.130.74-0.39-0.84-0.77-0.720.12-0.77-0.37-0.110.06-0.77-0.74-0.27-0.770.170.16-0.61
-0.07-0.020.15-0.48-0.22-0.07-0.39-0.23-0.260.380.110.260.24-0.190.260.36-0.05-0.230.250.240.070.250.130.080.0
-0.21-0.05-0.98-0.02-0.22-0.21-0.350.150.160.32-0.160.560.480.720.56-0.10.520.090.560.520.190.56-0.97-0.040.21
1.0-0.140.240.24-0.07-0.210.3-0.510.17-0.13-0.2-0.07-0.45-0.16-0.07-0.21-0.16-0.89-0.06-0.010.13-0.060.25-0.160.28
0.3-0.70.470.9-0.39-0.350.3-0.230.62-0.29-0.73-0.92-0.85-0.3-0.92-0.36-0.23-0.02-0.93-0.89-0.33-0.930.520.3-0.67
-0.510.2-0.18-0.13-0.230.15-0.51-0.23-0.22-0.320.270.190.630.240.190.53-0.170.690.180.28-0.680.18-0.210.33-0.26
0.17-0.87-0.110.74-0.260.160.170.62-0.22-0.12-0.91-0.49-0.520.18-0.49-0.170.430.03-0.5-0.52-0.16-0.5-0.020.21-0.46
-0.13-0.07-0.27-0.390.380.32-0.13-0.29-0.32-0.120.030.330.28-0.180.33-0.340.33-0.250.320.290.140.32-0.260.440.04
-0.20.970.08-0.840.11-0.16-0.2-0.730.27-0.910.030.570.56-0.160.570.24-0.220.050.580.570.240.580.01-0.330.63
-0.070.58-0.65-0.770.260.56-0.07-0.920.19-0.490.330.570.840.421.00.30.3-0.191.00.990.31.0-0.69-0.260.71
-0.450.49-0.56-0.720.240.48-0.45-0.850.63-0.520.280.560.840.360.840.470.160.260.830.86-0.150.83-0.60.110.3
-0.16-0.04-0.780.12-0.190.72-0.16-0.30.240.18-0.18-0.160.420.360.420.020.440.170.420.390.150.42-0.79-0.320.2
-0.070.58-0.65-0.770.260.56-0.07-0.920.19-0.490.330.571.00.840.420.30.3-0.191.00.990.31.0-0.69-0.260.71
-0.210.160.0-0.370.36-0.1-0.21-0.360.53-0.17-0.340.240.30.470.020.30.030.290.290.33-0.310.29-0.01-0.02-0.01
-0.16-0.23-0.55-0.11-0.050.52-0.16-0.23-0.170.430.33-0.220.30.160.440.30.030.040.30.210.310.3-0.5-0.070.19
-0.890.01-0.10.06-0.230.09-0.89-0.020.690.03-0.250.05-0.190.260.17-0.190.290.04-0.2-0.21-0.36-0.2-0.110.18-0.45
-0.060.59-0.65-0.770.250.56-0.06-0.930.18-0.50.320.581.00.830.421.00.290.3-0.20.980.321.0-0.68-0.270.72
-0.010.57-0.61-0.740.240.52-0.01-0.890.28-0.520.290.570.990.860.390.990.330.21-0.210.980.170.98-0.65-0.170.65
0.130.39-0.22-0.270.070.190.13-0.33-0.68-0.160.140.240.3-0.150.150.3-0.310.31-0.360.320.170.32-0.23-0.810.74
-0.060.59-0.64-0.770.250.56-0.06-0.930.18-0.50.320.581.00.830.421.00.290.3-0.21.00.980.32-0.68-0.270.72
0.25-0.11.00.170.13-0.970.250.52-0.21-0.02-0.260.01-0.69-0.6-0.79-0.69-0.01-0.5-0.11-0.68-0.65-0.23-0.680.15-0.32
-0.16-0.520.120.160.08-0.04-0.160.30.330.210.44-0.33-0.260.11-0.32-0.26-0.02-0.070.18-0.27-0.17-0.81-0.270.15-0.74
0.280.74-0.29-0.610.00.210.28-0.67-0.26-0.460.040.630.710.30.20.71-0.010.19-0.450.720.650.740.72-0.32-0.74
Click cells to compare fundamentals

Adial Pharmaceuticals Account Relationship Matchups

Adial Pharmaceuticals fundamentals Accounts

201920202021202220232024 (projected)
Ptb Ratio3.335.3214.311.780.650.68
Book Value Per Share18.128.04.723.082.874.97
Free Cash Flow Yield(0.27)(0.36)(0.24)(1.91)(2.2)(2.09)
Operating Cash Flow Per Share(16.08)(15.31)(16.07)(10.52)(4.78)(5.02)
Average Payables144.9K419.5K467.5K201.9K181.7K232.7K
Pb Ratio3.335.3214.311.780.650.68
Free Cash Flow Per Share(16.08)(15.31)(16.16)(10.52)(12.1)(12.71)
Roic(1.14)(2.73)(5.47)(3.99)(1.69)(1.77)
Net Income Per Share(21.8)(21.79)(26.12)(11.98)(4.92)(5.16)
Payables Turnover0.002978.69E-40.190.220.0044270.004206
Cash Per Share17.28.838.153.761.991.89
Pocfratio(3.75)(2.78)(4.2)(0.52)(0.39)(0.41)
Pfcf Ratio(3.75)(2.78)(4.18)(0.52)(0.47)(0.49)
Days Payables Outstanding122.9K419.8K1.9K1.7K82.4K84.6K
Income Quality0.740.70.620.880.970.51
Roe(1.2)(2.72)(5.54)(3.89)(1.71)(1.8)
Ev To Operating Cash Flow(2.68)(2.2)(3.71)(0.18)0.02620.0275
Pe Ratio(2.76)(1.95)(2.58)(0.46)(0.38)(0.4)
Return On Tangible Assets(1.12)(1.98)(2.87)(2.53)(1.48)(1.55)
Ev To Free Cash Flow(8.2)(2.68)(2.2)(3.69)(0.18)(0.17)
Earnings Yield(0.36)(0.51)(0.39)(2.18)(2.64)(2.51)
Intangibles To Total Assets8.03E-40.0010210.09490.128.26E-47.85E-4
Net Debt To E B I T D A0.550.830.40.30.280.42
Current Ratio14.243.412.372.674.94.46
Tangible Book Value Per Share18.17.983.762.422.864.81
Graham Number94.2762.652.6628.8217.8116.92
Shareholders Equity Per Share18.128.04.723.082.874.97
Graham Net Net18.9715.835.812.821.451.53
Enterprise Value Over E B I T D A(2.08)(1.54)(2.28)(0.15)0.02550.0268
Price Earnings Ratio(2.76)(1.95)(2.58)(0.46)(0.38)(0.4)
Price Book Value Ratio3.335.3214.311.780.650.68
Price Earnings To Growth Ratio0.04342.53(0.13)0.0084830.0069290.006583
Days Of Payables Outstanding122.9K419.8K1.9K1.7K82.4K84.6K
Price To Operating Cash Flows Ratio(3.75)(2.78)(4.2)(0.52)(0.39)(0.41)
Price To Free Cash Flows Ratio(3.75)(2.78)(4.18)(0.52)(0.47)(0.49)

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Adial Pharmaceuticals is a strong investment it is important to analyze Adial Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Adial Pharmaceuticals' future performance. For an informed investment choice regarding Adial Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Adial Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
For more information on how to buy Adial Stock please use our How to buy in Adial Stock guide.
You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Adial Pharmaceuticals. If investors know Adial will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Adial Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.94)
Return On Assets
(1.04)
Return On Equity
(3.21)
The market value of Adial Pharmaceuticals is measured differently than its book value, which is the value of Adial that is recorded on the company's balance sheet. Investors also form their own opinion of Adial Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Adial Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Adial Pharmaceuticals' market value can be influenced by many factors that don't directly affect Adial Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Adial Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Adial Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Adial Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.